NEX-I, Inc.
PrivateLast Round
Private Equity
May 15, 2026
Est. Valuation
$127.4M
Total Funding Raised
$101.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NEX-I, Inc. is a biotechnology company that develops next-generation immunotherapeutics to overcome resistance to cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEX-I, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NEX-I, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 15, 2026 | ||||
| Series B | Aug 12, 2025 | ||||
| Series A | Oct 7, 2022 | ||||
| Pre Seed | Dec 22, 2021 |
NEX-I, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Pre Seed, Private Equity, Series A, Series B |
| InterVest | Private Equity |
| DSC Investment | Pre Seed, Private Equity, Series B, Series A |
| K2 Investment Partners | Private Equity, Series B |
| KB Investment | Private Equity, Series B |
| TS Investment | Private Equity, Series A, Series B |
| DS Asset Management | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2025
$44M round with participation from CJ Investment and IBK.
NEX-I, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NEX-I, Inc.'s valuation, stock price, and market status.